Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 631
2021 49
Text availability
Article attribute
Article type
Publication date

Search Results

665 results
Results by year
Filters applied: . Clear all
Page 1
Treatment for emerging viruses: Convalescent plasma and COVID-19.
Brown BL, McCullough J. Brown BL, et al. Transfus Apher Sci. 2020 Jun;59(3):102790. doi: 10.1016/j.transci.2020.102790. Epub 2020 Apr 20. Transfus Apher Sci. 2020. PMID: 32345485 Free PMC article. Review.
This convalescent plasma therapy is of particular interest when a vaccine or specific therapy is not yet available for emerging viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19
This convalescent plasma therapy is of particular interest when a vaccine or specific therapy is not yet available for emergin …
Deployment of convalescent plasma for the prevention and treatment of COVID-19.
Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Bloch EM, et al. J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745. J Clin Invest. 2020. PMID: 32254064 Free article. Review.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven options for prophylaxis for those who have been exposed to …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID
Convalescent plasma in Covid-19: Possible mechanisms of action.
Rojas M, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y, Camacho B, Gallo JE, Rojas-Villarraga A, Ramírez-Santana C, Díaz-Coronado JC, Manrique R, Mantilla RD, Shoenfeld Y, Anaya JM. Rojas M, et al. Autoimmun Rev. 2020 Jul;19(7):102554. doi: 10.1016/j.autrev.2020.102554. Epub 2020 May 5. Autoimmun Rev. 2020. PMID: 32380316 Free PMC article. Review.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible of the coronavirus disease 2019 (COVID-19) pandemic. ...Meanwhile the current pandemic has called attention over old therapeutic tools to treat infectious disease …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible of the coronavirus disease 2019 ( …
Convalescent plasma transfusion for the treatment of COVID-19: Systematic review.
Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A. Rajendran K, et al. J Med Virol. 2020 Sep;92(9):1475-1483. doi: 10.1002/jmv.25961. Epub 2020 May 12. J Med Virol. 2020. PMID: 32356910 Free PMC article.
The recent emergence of coronavirus disease 2019 (COVID-19) pandemic has reassessed the usefulness of historic convalescent plasma transfusion (CPT). ...We included five studies reporting CPT to COVID-19 patients. The main findings from a …
The recent emergence of coronavirus disease 2019 (COVID-19) pandemic has reassessed the usefulness of historic convalescent
Convalescent Plasma to Treat COVID-19: Possibilities and Challenges.
Roback JD, Guarner J. Roback JD, et al. JAMA. 2020 Apr 28;323(16):1561-1562. doi: 10.1001/jama.2020.4940. JAMA. 2020. PMID: 32219429 No abstract available.
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Shen C, et al. JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783. JAMA. 2020. PMID: 32219428 Free PMC article.
It is critical to find new treatments. OBJECTIVE: To determine whether convalescent plasma transfusion may be beneficial in the treatment of critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecti …
It is critical to find new treatments. OBJECTIVE: To determine whether convalescent plasma transfusion may be beneficial in th …
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Ren L, Wei Q, Mei H, Hu C, Tao C, Yang R, Wang J, Yu Y, Guo Y, Wu X, Xu Z, Zeng L, Xiong N, Chen L, Wang J, Man N, Liu Y, Xu H, Deng E, Zhang X, Li C, Wang C, Su S, Zhang L, Wang J, Wu Y, Liu Z. Li L, et al. JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044. JAMA. 2020. PMID: 32492084 Free PMC article. Clinical Trial.
IMPORTANCE: Convalescent plasma is a potential therapeutic option for patients with coronavirus disease 2019 (COVID-19), but further data from randomized clinical trials are needed. ...Among those with severe disease, the primary outcome occurred in 91 …
IMPORTANCE: Convalescent plasma is a potential therapeutic option for patients with coronavirus disease 2019 (COVID- …
Convalescent plasma as a potential therapy for COVID-19.
Chen L, Xiong J, Bao L, Shi Y. Chen L, et al. Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27. Lancet Infect Dis. 2020. PMID: 32113510 Free PMC article. No abstract available.
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?
Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y. Tiberghien P, et al. Vox Sang. 2020 Aug;115(6):488-494. doi: 10.1111/vox.12926. Epub 2020 May 3. Vox Sang. 2020. PMID: 32240545 Review.
Plasma provided by COVID-19 convalescent patients may provide therapeutic relief as the number of COVID-19 cases escalates steeply worldwide. Prior findings in various viral respiratory diseases including SARS-CoV-related pn
Plasma provided by COVID-19 convalescent patients may provide therapeutic relief as the number of COVID-
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.
Barone P, DeSimone RA. Barone P, et al. Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12. Transfusion. 2020. PMID: 32374891 Free PMC article. Review.
Case series studying convalescent plasma use in the treatment of COVID-19 have been promising, but additional, high-quality studies are needed to determine the efficacy of the treatment when applied for prophylaxis, for early phases of illness, and for …
Case series studying convalescent plasma use in the treatment of COVID-19 have been promising, but additional, h …
665 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback